Funding round
Alto Pharmacy Series C
Alto Pharmacy, which works in prescription medication fulfillment services in San Francisco, raised $50M in a Series C round announced on 5 Dec 2018. It is Alto Pharmacy's first venture round on record.
$50M
Amount raised
Not disclosed
Post-money valuation
Valuation
What this round says about the price
Alto Pharmacy did not disclose a valuation in this round. It is Alto Pharmacy's first venture round on record, 3 years after it was founded in 2015. It is 10% of the $500M Alto Pharmacy has raised in the venture rounds on record. Alto Pharmacy raised again 13 months later: a Series D round of $250M in Jan 2020, at $700M post-money.
Alto Pharmacy's funding rounds
Alto Pharmacy has 4 venture rounds on record and 1 other deal. This one is highlighted.
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, geographic expansion, sales and marketing, scaling operations and working capital.
- Product development
- Geographic expansion
- Sales and marketing
- Scaling operations
- Working capital
Comparable rounds
How it compares
The closest in time, other companies' Series C rounds in Drug Stores & Pharmacies:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Fuze Health Drug Stores & Pharmacies | 5 Dec 2018 | $50M | not disclosed | Zola Global and Greenoaks |
| Drug Stores & Pharmacies | 28 Jan 2019 | $100M | $1.00B | Growth-stage investor |
| PharmEasy Drug Stores & Pharmacies | 26 Sep 2018 | $50M | not disclosed | Eight Roads |
| Capsule Drug Stores & Pharmacies | 30 Sep 2019 | $200M | not disclosed | Technology Crossover Ventures |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did Alto Pharmacy raise in its Series C round?
Alto Pharmacy raised $50M in its Series C round, announced in Dec 2018.
What was Alto Pharmacy's valuation at the Series C round?
It was not disclosed.
Did Alto Pharmacy raise again after this round?
Yes: a Series D round in Jan 2020 of $250M at $700M post-money.